Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

Current Medical Research and Opinion
A J ClarkK Simpson

Abstract

To evaluate effectiveness and safety information of transdermal fentanyl (TDF) (Duragesic/Durogesic) and sustained-release oral morphine (SRM) in cancer pain (CP) and chronic non-cancer pain (NCP), a pooled analysis was conducted on datasets of published, open label, uncontrolled (no comparator group) and randomised controlled (with SRM as comparator) studies of TDF. Eight trials with treatment durations of at least 28 days met the inclusion criteria. The effectiveness analysis assessed changes in average pain and pain 'right now' scores between baseline and Day 28. The safety analysis evaluated the incidence of adverse events (AEs) reported within the first 28 days of treatment with TDF or SRM. Subgroup analyses included pain type, gender, age, weight, and body mass index. Pooled efficacy data were available from 1220 patients; these showed that both TDF and SRM were effective in improving pain 'right now' scores (0-100 scale) from baseline to Day 28. The improvement was significantly more pronounced in the TDF treatment group (-26.7 +/- 31.3 for TDF, -18.7 +/- 30.9 for SRM, p = 0.002). This favourable effect of TDF was most apparent amongst patients with NCP. Data concerning AEs were available from over 2500 patients with CP ...Continue Reading

References

Apr 1, 1995·Anti-cancer Drugs·B Donner, M Zenz
May 1, 1997·Palliative Medicine·W YeoP J Johnson
May 28, 1998·Journal of Pain and Symptom Management·A A MegensF H Awouters
May 10, 2001·Lancet·S C WeissE J Emanuel
May 23, 2001·Journal of Pain and Symptom Management·M NugentS H Ahmedzai
Feb 5, 2003·Journal of Pain and Symptom Management·Rainer SabatowskiLukas Radbruch
Oct 31, 2003·Journal of Pain and Symptom Management·Roger ChouMark Helfand
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Kyriaki MystakidouLambros Vlahos
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·K MilliganL Haazen
Mar 10, 2004·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·C P N WatsonM L Chipman
Mar 18, 2004·Current Medical Research and Opinion·Mohamed Omar TawfikUNKNOWN FEN-INT-20 Study Group

❮ Previous
Next ❯

Citations

Jul 14, 2009·International Journal of Clinical Oncology·Takanori MatsuiJunichi Sakamoto
Sep 20, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·W GreinerR Sabatowski
Jan 19, 2002·European Journal of Pain : EJP·Y Huang
Jun 1, 2002·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Lukas RadbruchG Nuyts
Feb 10, 2012·World Journal of Urology·Pia BaderJan H Vranken
Feb 28, 2008·Drug Development and Industrial Pharmacy·Dave A MillerRobert O Williams
Dec 22, 2005·Current Medical Research and Opinion·Gayatri SathyanSuneel Gupta
Sep 22, 2007·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Shefali AgarwalSrinivasa N Raja
Jun 12, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Oscar CorliGiovanni Apolone
Jan 17, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Farzana MitraGary Williams
Jan 15, 2016·European Journal of Clinical Pharmacology·Astrid W OostenRon H J Mathijssen
Jul 25, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Hyuk Soon ChoiHo Sang Ryu
Feb 16, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hans G KressThomas Wagner
Mar 14, 2007·The Journal of Pain : Official Journal of the American Pain Society·Boris ZernikowBrian Anderson
Mar 21, 2008·European Journal of Pain : EJP·Sebastiano MercadanteSalvatore Mangione
Mar 28, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P TucciL Romanelli
Apr 27, 2011·British Journal of Haematology·John A SnowdenUNKNOWN Haemato-oncology Task Force of British Committee for Standards in Haematology and UK Myeloma Forum
Feb 3, 2011·British Journal of Clinical Pharmacology·Andrew J McLachlanFiona M Blyth
Jul 26, 2005·Peptides·Richard J Bodnar, Gad E Klein
Jun 9, 2015·The Journal of Pain : Official Journal of the American Pain Society·Astrid W OostenCarin C D van der Rijt
Feb 21, 2014·Journal of Pain & Palliative Care Pharmacotherapy·Sam H Ahmedzai
Dec 6, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·O CorliM Montanari
Aug 28, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sarah SlootSam H Ahmedzai
Sep 3, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Shao-Zhi Xing, Ying Zhang
May 22, 2018·Annals of the New York Academy of Sciences·Javier MurielAna M Peiró
Oct 8, 2013·The Cochrane Database of Systematic Reviews·Gina HadleyPhilip J Wiffen
Dec 9, 2017·Pain Practice : the Official Journal of World Institute of Pain·Oscar CorliRaffaella Antonione

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.